HighVista Strategies LLC - AMYLYX PHARMACEUTICALS INC ownership

Quarter-by-quarter ownership
HighVista Strategies LLC ownership history of AMYLYX PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$482,450
+62.7%
26,349
+91.7%
0.22%
+64.0%
Q2 2023$296,54413,7480.14%
Other shareholders
AMYLYX PHARMACEUTICALS INC shareholders Q4 2023
NameSharesValueWeighting ↓
Bain Capital Life Sciences Investors, LLC 1,948,214$37,523,0004.40%
Boxer Capital, LLC 2,200,000$42,372,0002.68%
Perceptive Advisors 3,540,408$68,188,0002.14%
Altium Capital Management LP 200,000$3,852,0001.54%
Alpha Wave Global, LP 700,635$13,494,0001.39%
Ikarian Capital, LLC 350,800$6,757,0001.23%
TYBOURNE CAPITAL MANAGEMENT (HK) LTD 768,603$14,804,0001.07%
683 Capital Management, LLC 677,714$12,958,0000.92%
Ikarian Capital, LLC 246,554$4,750,0000.87%
Tri Locum Partners LP 80,459$1,550,0000.64%
View complete list of AMYLYX PHARMACEUTICALS INC shareholders